NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supplying essential chemical intermediates that form the backbone of critical pharmaceutical products. Among these, 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one, identified by CAS 199327-61-2, stands out for its pivotal role in the synthesis of Gefitinib. Gefitinib is a highly effective targeted therapy drug used in the treatment of specific types of cancer, particularly those with mutations in the epidermal growth factor receptor (EGFR). The development of such targeted therapies represents a significant advancement in oncology, offering more precise and less toxic treatment options.

The chemical makeup of this intermediate, with its molecular formula C16H21N3O4 and a molecular weight of approximately 319.36, is crucial for its function within the complex multi-step synthesis of Gefitinib. As a leading supplier of pharmaceutical intermediates, NINGBO INNO PHARMCHEM CO.,LTD. ensures that the highest standards of purity and quality are maintained for CAS 199327-61-2. This meticulous attention to detail is vital, as impurities in intermediates can compromise the safety and efficacy of the final drug product. The role of NINGBO INNO PHARMCHEM CO.,LTD. as a reliable Gefitinib impurity supplier is therefore of paramount importance.

The demand to buy 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one highlights its fundamental importance in the API manufacturing supply chain. Pharmaceutical companies rely on consistent and high-quality supplies to meet patient needs. By providing this key ingredient, NINGBO INNO PHARMCHEM CO.,LTD. actively contributes to the global fight against cancer. Our expertise in chemical synthesis and our commitment to innovation make us a trusted partner for pharmaceutical manufacturers seeking to develop groundbreaking treatments. This commitment solidifies our position in the market for medicinal chemistry building blocks.

In the realm of targeted cancer therapy, the precision of each step in the synthesis process is critical. 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one exemplifies the essential nature of specialized chemical intermediates. Its contribution to the production of Gefitinib means it plays a direct role in improving patient outcomes and advancing oncological care. NINGBO INNO PHARMCHEM CO.,LTD. is proud to be a part of this vital industry, providing the chemical foundations for medical breakthroughs.